Johnson & Johnson vs Abrdn Physical Platinum Shares ETF — how do they compare? Johnson & Johnson trades at $258.91 (market cap $626.09B), while Abrdn Physical Platinum Shares ETF trades at $16.16. The key difference: Johnson & Johnson pays a 2.06% dividend while Abrdn Physical Platinum Shares ETF pays none, and Johnson & Johnson is trading nearer its 52-week high, Abrdn Physical Platinum Shares ETF nearer its low. Which is the better fit depends on your goals.
| JNJ | PPLT | |
|---|---|---|
Market Cap | $626.09B | — |
Volume | 6,156,228 | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $267.24 | $25.23 |
52-Week Low | $172.78 | $11.95 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | — |
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →